Mathias Färnegårdh
Mathias Färnegårdh publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology, on topics such as Estrogen and related hormone effects, Drug Transport and Resistance Mechanisms and Cholesterol and Lipid Metabolism.
- World rank
- #2,474,625 of 7,710,434 ranked researchers
- Rank in Sweden
- #31,838 of 71,437
- Works
- 28
- Citations
- 1.6k
- Citations per work
- 56.3
What does Mathias Färnegårdh research?
Mathias Färnegårdh's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (33%), Neuroscience (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1242.1%
- Medicine1242.1%
- Life Sciences1138.6%
- Everything else519.3%
- 1Molecular Biology19% of their works
- 2Endocrinology, Diabetes and Metabolism19% of their works
- 3Oncology14% of their works
- 4Genetics14% of their works
- 5Surgery9% of their works
- 6Cellular and Molecular Neuroscience5% of their works
Research topics
- Estrogen and related hormone effects
- Drug Transport and Resistance Mechanisms
- Cholesterol and Lipid Metabolism
- Thyroid Disorders and Treatments
- Retinoids in leukemia and cellular processes
- Metal-Catalyzed Oxygenation Mechanisms
- Growth Hormone and Insulin-like Growth Factors
- Hormonal Regulation and Hypertension
Which keywords describe Mathias Färnegårdh's research?
The keywords of their largest research topics: Nuclear Receptors, Estrogen, Metabolism, Receptor, ATP-dependent Transporters, Multidrug Resistance, Atherosclerosis and Cholesterol.
- Retinoic Acid
- Metalloenzyme
- IGF-1
- Aldosterone
- Thyroid Hormone
- Cholesterol
- Multidrug Resistance
- Receptor
- Estrogen
- Nuclear Receptors
- Metabolism
- ATP-dependent Transporters
- Atherosclerosis
- Thyroid Dysfunction
- Acute Promyelocytic Leukemia
- Dioxygen Activation
- Insulin-like Growth Factors
- Primary Aldosteronism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Nuclear Receptors183 topics
- Estrogen81 topic
- Metabolism82 topics
- Receptor81 topic
- ATP-dependent Transporters71 topic
- Multidrug Resistance71 topic
- Atherosclerosis51 topic
- Cholesterol51 topic
- Thyroid Dysfunction41 topic
- Thyroid Hormone41 topic
- Acute Promyelocytic Leukemia31 topic
- Aldosterone31 topic
- Dioxygen Activation31 topic
- IGF-131 topic
- Insulin-like Growth Factors31 topic
- Metalloenzyme31 topic
- Primary Aldosteronism31 topic
- Retinoic Acid31 topic
Where does Mathias Färnegårdh work?
Mathias Färnegårdh's main affiliation in the publication record is Karo Pharma (Sweden), Sweden.
How many publications and citations does Mathias Färnegårdh have?
OpenAlex counts 28 works and 1,576 citations for Mathias Färnegårdh, an h-index of 17, ranking #2,474,625 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mathias Färnegårdh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.